Several recent actions by UBI's management raise concerns for shareholders.
Capital Raise Timing: The timing of the capital raise announcement relative to FDA approval and the CEO's exercise of stock options merits clarification.
Discounted Share Issuance: The significant discount offered to institutional investors during the capital raise following FDA approval warrants a full explanation. Shareholders deserve to understand the rationale behind this decision, especially considering the positive impact of FDA approval on the company's prospects.
Capital Raise Partner Selection: The selection of a capital raise partner with close ties to a major UBI shareholder and a director with a significant holding in UBI requires careful scrutiny. This potential conflict of interest necessitates transparency regarding the selection process and justification for the chosen partner.
Communication and Transparency: A lack of transparency regarding the nature and timing of recent discussions with the FDA, as well as the absence of a clear record date for the capital raise, are concerning. Timely and clear communication with shareholders is essential for informed decision-making.
These concerns highlight the critical importance of management actions that demonstrably prioritize long-term shareholder value. Shareholders have a right to expect clear communication and a compelling rationale behind decisions, especially those that may have a significant dilutive effect.
To better serve shareholder value, the capital raise could have been done at a premium to institution investors as they already received FDA approval, cancel capital raise 20c free option attachment as it fix a low ball options for no reason as FDA approval is already obtained, allow all shareholder to vote on decision making process not just that bought on or before 14th March.
- Forums
- ASX - By Stock
- UBI
- Ann: Notice of Meeting of Stockholders on 10 April 2024
Ann: Notice of Meeting of Stockholders on 10 April 2024, page-15
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UBI (ASX) to my watchlist
|
|||||
Last
12.5¢ |
Change
-0.015(10.7%) |
Mkt cap ! $37.25M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 12.5¢ | $61.45K | 469.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 57870 | 12.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 104965 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 52870 | 0.125 |
2 | 25000 | 0.120 |
1 | 195 | 0.110 |
1 | 27281 | 0.105 |
3 | 125000 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 104965 | 2 |
0.145 | 77314 | 2 |
0.150 | 135340 | 5 |
0.155 | 125004 | 4 |
0.160 | 99420 | 2 |
Last trade - 14.46pm 12/09/2024 (20 minute delay) ? |
Featured News
UBI (ASX) Chart |